ArticleFrontiers in surgery2026
Application and prognostic analysis of endoscopic sinus surgery combined with multidisciplinary team management in rhino-orbito-cerebral mucormycosis.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the clinical value of endoscopic sinus surgery (ESS) combined with a multidisciplinary team (MDT) approach in rhino-orbito-cerebral mucormycosis (ROCM) and identify independent prognostic factors. Methods: This retrospective cohort study enrolled 22 consecutive patients with ROCM managed by a standardized MDT protocol between January 2020 and June 2024.Clinical data covering endoscopic surgical strategies and cross-specialty MDT collaboration were systematically extracted. Univariate chi-square analysis and multivariate binary logistic regression were performed to screen mortality predictors. Kaplan-Meier survival curves with log-rank tests were generated for survival comparisons. Results: The cohort included 14 males and 8 females with a mean age of 58.6 ± 10.3 years. Diabetes mellitus was the dominant underlying comorbidity (18/22, 81.8%), among whom six patients presented with diabetic ketoacidosis (27.3%). 18 patients (81.8%) received endoscopic debridement, and 10 of these surgical patients (55.6%) underwent concurrent endoscopic optic nerve decompression. Histopathology confirmed characteristic broad, aseptate, right-angle branching hyphae; Rhizopus species were isolated from 6 patients via fungal culture and metagenomic next-generation sequencing (mNGS). At the predefined 6-month primary follow-up endpoint, 12 patients (54.5%) met composite remission criteria, while 10 patients (45.5%) died of ROCM-related complications. Multivariate logistic regression identified intracranial extension as the sole independent risk factor for mortality (OR = 28.5, 95% CI: 2.1-387.4, Conclusion: Endoscopic sinus surgery serves as the core intervention to eradicate primary sinonasal lesions in ROCM. Structured MDT collaboration optimizes surgical timing and standardized comorbidity management. Early precise endoscopic debridement combined with standardized long-term antifungal therapy substantially improves clinical outcomes. Timely endoscopic debridement within 72 h and strict glycemic control represent critical modifiable factors to reduce mortality risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.